Literature DB >> 9874851

Neurofibromatosis 1 in childhood.

K N North1.   

Abstract

Neurofibromatosis 1 (NF1) is an autosomal-dominant disorder with an incidence of approximately 1 in 3,000. The cardinal features of the disorder are cafe au lait spots, axillary freckling, cutaneous neurofibromas, and iris hamartomas (Lisch nodules). Common complications include learning disability, scoliosis, and optic gliomas. Other complications (e.g., peripheral nerve malignancy, bony deformities, and epilepsy) are individually rare. The mainstay of care for patients with NF1 is anticipatory guidance, and the early detection and symptomatic treatment of disease complications. Counseling of patients and their families should provide a realistic overview of possible disease complications, while emphasizing that most individuals with NF1 lead healthy and productive lives. The gene for NF1 has been identified, and future cell biology research will focus on understanding the pathogenetic mechanisms that underly the diverse manifestations of the disorder.

Entities:  

Mesh:

Year:  1998        PMID: 9874851     DOI: 10.1016/s1071-9091(98)80002-8

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  4 in total

Review 1.  Neurocognitive dysfunction in children with neurofibromatosis type 1.

Authors:  Tena L Rosser; Roger J Packer
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

2.  Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.

Authors:  Kavitha Nutakki; Cynthia M Hingtgen; Patrick Monahan; James W Varni; Nancy L Swigonski
Journal:  Health Qual Life Outcomes       Date:  2013-02-21       Impact factor: 3.186

3.  Massive Plexiform Neurofibroma of the Neck and Larynx.

Authors:  Mohammad Kamal Mobashir; Abd ElRaof Said Mohamed; Mohammad Waheed El-Anwar; Ahmad Ebrahim El Sayed; Mouhamad A Fouad
Journal:  Int Arch Otorhinolaryngol       Date:  2014-12-12

4.  Adaptive behavior in young children with neurofibromatosis type 1.

Authors:  Bonita P Klein-Tasman; Alina M Colon; Natalie Brei; Faye van der Fluit; Christina L Casnar; Kelly M Janke; Donald Basel; Dawn H Siegel; Jasmine A Walker
Journal:  Int J Pediatr       Date:  2013-11-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.